The practice of once-daily aminoglycoside dosing in Canada: A national survey

Canadian Journal of Hospital Pharmacy

Volumn 52, Issue 1, 1999, Pages 12-17

  Gin, Alfred S ^a   Ariano, Robert ^a   Zelenitsky, Sheryl ^a   Ducharme, Murray ^a   Rodvold, Keith A ^a   Zhanel, George A ^a  

^a NONE

Author keywords

Aminoglycoside; Survey

Indexed keywords

AMINOGLYCOSIDE;

ABDOMINAL INFECTION; ARTICLE; BACTEREMIA; COST BENEFIT ANALYSIS; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HOSPITAL; PNEUMONIA; SEPSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; URINARY TRACT INFECTION;

EID: 0032921185     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rotschafer JC, Rybak MJ. Single daily dosing of aminoglycosides: a commentary. Ann Pharmacother 1994;28:797-801.
2. Bates RD, Nahata MC. Once-daily administration of aminoglycosides. Ann Pharmacother 1994;28:757-66.
3. Parker SE, Davey PG. Once-Daily aminoglycoside administration in gramnegative sepsis. Economic and practical aspects. Pharmacoeconomics 1995;393-402.
4. Preston SL, Briceland LL. Single daily dosing of aminoglycosides. Pharmacotherapy 1995;15:297-316.
5. Zhanel GG, Ariano RE. Once daily aminoglycoside dosing maintained efficacy with reduced nephrotoxicity? Ren Fail 1992; 14:19.
6. Marra F, Partovi N, Jewesson P. Aminoglycoside administration as a single daily dose. An improvement to current practice or a repeat of previous errors? Drugs 1996;52:344-70.
7. Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993;341(8841):335-9.
8. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993; 199:584-93.
9. Nicolau DP, Freeman CD, Belliveau PP et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995:650-5.
10. Galloe AM, Graudal N, Christesen HR, Kampmann JP. Aminoglycosides: single or multiple daily dosing? A metaanalysis on efficacy and safety. Eur J Clin Pharmacol 1995;48:39-43.
11. Hatala R, Dinh T, Cook DJ. Once-daily aminoglyccoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996; 124:717-25.
12. Barza M, Ioannidis JPA, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycoside: a metaanalysis. Br Med J 1996;312:338-45.
13. Munckhof WJ, Grayson ML, Tumidge JD. A metaanalysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 1996;34:645-63.
14. Ferriols-Lisart R, Alos-Almina M. Effectiveness and safety of oncedaily aminoglycosides: a metaanalysis. Am J Health Syst Pharm 1996;53:1141-50.
15. Bailey TC, Little JR, Littenberg B, Reichley RM, Dunagan WC. A metaanalysis of extendedinterval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997;24:786-95.
16. Ali MZ, Goetz MB. A metaanalysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing aminoglycosides. Clin Infect Dis 1997;24:796-809.
17. Hatala R, Dinh TT, Cook DJ. Single daily dosing of aminoglycosides in immunocompromised adults: A systematic review. Clin Infect Dis 1997;24:810-5.
18. Rodvold KA, Danzinger LH, Quinn JP. Single daily doses of aminoglycosides. Lancet 1997;350:141-2
19. Schumock GT, Raber SR, Crawford S, Naderer OJ, Rodvold KA. National survey of once daily dosing of aminoglycoside antibiotics. Pharmacotherapy 1995; 15:201-9.
20. Ontario College of Pharmacists. Once daily aminoglycosides. Drug Information Centre Exchange 1994;19:2.
21. Canadian Council on Hospital Accreditation. Canadian directory of accredited health care facilities. Ottawa: Canadian Council on Hospital Accreditation, 1995.
22. McCormack JP, Jewesson PJ. A critical reevaluation of the "therapeutic range" of aminoglycosides. Clin Infect Dis 1992; 14:320-39.
23. Bertino JS, Rotschafer JC. Single daily dosing of aminoglycosidesa concept whose time has not yet come. Clin Infect Dis 1997;24:820-3.
24. Gilbert DN. Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides. Clin Infect Dis 1997;24:816-9.
25. Gilbert DN. Aminoglycosides. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of of infectious diseases. New York, Churchill Livingstone 1995:279-306.
26. Barclay ML, Duffull SB, Begg EJ, Buttmore RC. Experience of oncedaily aminoglycoside dosing using a target area under the concentration time curve. Aust NZ J Med 1995;24:230-5.
27. Begg EJ, Barclay ML, Duffull SB. A suggested approach to oncedaily aminoglycoside dosing. Br J Clin Pharmacol 1995;39:605-9.
28. Prober CG. Stevenson DK, Benitz WE. The use of antibiotics in neonates weighing less than 1200 grams. Pediatr Infect Dis J 1990;9:111-21.
29. Hindmarsh KW, Nation RL, Williams GL, John E, French JN. Pharmacokinetics of gentamicin in very low birth weight preterm infants. Eur J Clin Pharmacol 1993;649-651
30. Demczar DJ, Nafziger AN, Bertino JS. Pharmacokinetics of gentamicin at traditional versus high doses: implications for oncedaily aminoglycoside dosing. Antimicrob Agents Chemother 1997;41:1115-9
31. Periti P. Pharmacoeconomic evaluation of once-daily aminoglycoside treatment. J Chemother 1995;7:38094.
32. Mithani H, Brown G. The economic impact of once-daily versus conventional administration of gentamicin and tobramycin. Pharmacoeconomics 1996;11:494-503.
33. Hitt CH, Klepser ME, Nightingale CH, Nicolau DP. Pharmacoeconomic impact of once daily aminoglycoside program [abstract no. 107]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: American Society of Microbiology, 1995:348.
34. Smaill, F. Commentary: single daily dose of aminoglycoside is the preferred mode of administration. Br Med J 1996;312:34-15.